On the Record · Rxo
Rxo acquisitions, on the record
The businesses Rxo bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
CoyoteWord for word“We acquired Coyote for $1.038 billion in cash, subject to certain additional customary adjustments.” 10-K for 2024 | acquisition | — | $1.038 billion in cash |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Goodwill from acquisitions |
|---|---|---|
| 2022-12-31 | $0 | — |
| 2023-12-31 | $0 | — |
| 2024-12-31 | $1.02 billion | $493 million |
| 2025-12-31 | $10 million | — |
Deal filings since 2016
- 2026-10-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2026-02-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2026-02-06 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-09-16 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2024-09-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-08-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-08-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-06-24 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-04-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-11-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-10-25 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-10-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Rxo’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-09. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.